Lowmolecular heparins in the treatment of APS-nephropathy in primary and secondary antiphospholipid syndrome
Aim. To evaluate efficacy of lowmolecular heparin enoxaparin in the treatment of nephropathy in patients with primary and secondary antiphospholipid syndrome (APS). Material and methods. A total of 11 APS-nephropathy patients participated in the study. Of them 8 patients had primary APS and 3 patien...
Main Authors: | N L Kozlovskaya, E A Shakhnova, V V Kushnir, E M Shilov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
"Consilium Medicum" Publishing house
2004-09-01
|
Series: | Терапевтический архив |
Subjects: | |
Online Access: | https://ter-arkhiv.ru/0040-3660/article/view/29889 |
Similar Items
-
What nephrolopathologists need to know about antiphospholipid syndrome-associated nephropathy: Is it time for formulating a classification for renal morphologic lesions?
by: Muhammed Mubarak, et al.
Published: (2014-01-01) -
Catastrophic antiphospholipid syndrome: a clinical review
by: Ali Nayer, et al.
Published: (2014-01-01) -
Concurrent arterial and venous thrombosis in a patient with catastrophic antiphospholipid syndrome
by: Muhammad Shoaib Khan, et al.
Published: (2021-07-01) -
Renal Involvement in Antiphospholipid Syndrome
by: Alonso Turrent-Carriles, et al.
Published: (2018-05-01) -
Similarities of antiphospholipid antibodies in HIT and APS patients with heparin-platelet factor 4 antibodies
by: Imene Hocine
Published: (2022-05-01)